Profil
Andrew John Matthew Clark was the founder of Reabourne Ltd., which was founded in 1995 where he held the title of Portfolio Manager from 1995 to 2003.
He is currently the Chairman-Supervisory Board at vasopharm GmbH.
Dr. Clark's former positions include Director at Liminal BioSciences, Inc., Senior Independent Non-Executive Director at Lifeline Scientific, Inc., and Director at Hologic Ltd. Dr. Clark received a doctorate degree from the University of St. Andrews.
Aktiva positioner av Andrew Clark
| Företag | Position | Start |
|---|---|---|
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Ordförande | - |
Tidigare kända positioner av Andrew Clark
| Företag | Position | Slut |
|---|---|---|
Reabourne Ltd. | Grundare | 2003-01-01 |
| LIMINAL BIOSCIENCES INC. | Direktör/Styrelseledamot | - |
| LIFELINE SCIENTIFIC, INC | Direktör/Styrelseledamot | - |
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Researches and develops medical diagnostic products | Direktör/Styrelseledamot | - |
Andrew Clarks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Liminal BioSciences, Inc.
Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Lifeline Scientific, Inc.
Lifeline Scientific, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and services | Health Technology |
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Researches and develops medical diagnostic products | Health Technology |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
University of St. Andrews
University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reabourne Ltd. |
















